By Laura Lutz
Washington, Dec. 6 - CeNeS Pharmaceuticals plc settled a private placement of shares for £4,820,998.
The company sold 74,169,194 shares to institutional and other investors for 6.5p per share.
JM Finn & Co Ltd. acted as placement agent.
Proceeds will be used to develop the company's portfolio of products.
Based in Cambridge, England, CeNeS is a biopharmaceutical company focused on pain management products.
| Issuer: | CeNeS Pharmaceuticals plc
|
| Issue: | Ordinary shares
|
| Amount: | £4,820,998
|
| Shares: | 74,169,194
|
| Price: | 6.5p
|
| Warrants: | No
|
| Agent: | JM Finn & Co Ltd.
|
| Settlement date: | Dec. 6
|
| Stock symbol: | London: CEN
|
| Stock price: | 6.75 at close Dec. 6
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
